1/17
  • Pages
  • Editions
01 Cover
02 Editor's Letter
03 Editorial Board
04 Contents
05 News
06 Gene editing bill: encouraging innovation or adding complexity?
07 All in the timing
08 Solving the PCT Priority problem
09 G 2/21: how to support inventive steps in patentability
10 A guide for life sciences entrepreneurs
11 The fall of COVID-19 and the rise of antimicrobial resistance
12 Predicting the unpredictable during pregnancy
13 Pandemic blues: the global approach to COVID-related IP
14 Psychedelics: from fungi and plants to patents
15 When alliances fail, is arbitration the answer?
16 Movers & Shakers
17 Contact us

C O V E R S T O R Y


Gene agenda

Will the UK‘s new gene-editing rules benefit IP owners?


Psychedelic trip

Mind-altering patents from fungi and plants


A guide for startups

IP tips for small companies with plenty to lose


EPO referrals

Analysis of inventive step, entitlement to priority


and much more…

ACCESS THE ISSUE >>